These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 17211914
1. Synthetic mimetics of the CD4 binding site of HIV-1 gp120 for the design of immunogens. Franke R, Hirsch T, Overwin H, Eichler J. Angew Chem Int Ed Engl; 2007; 46(8):1253-5. PubMed ID: 17211914 [No Abstract] [Full Text] [Related]
2. A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120. Neffe AT, Meyer B. Angew Chem Int Ed Engl; 2004 May 24; 43(22):2937-40. PubMed ID: 15170309 [No Abstract] [Full Text] [Related]
3. Functional design of potential inhibitors of human immunodeficiency virus (HIV) binding to CD4+ target cells: a molecular model of gp120 predicts ligand binding. Gabriel JL, Mitchell WM. Drug Des Discov; 1996 Oct 24; 14(2):103-14. PubMed ID: 9010617 [Abstract] [Full Text] [Related]
5. Glycosylation assists binding of HIV protein gp120 to human CD4 receptor. Wilhelm D, Behnken HN, Meyer B. Chembiochem; 2012 Mar 05; 13(4):524-7. PubMed ID: 22266649 [Abstract] [Full Text] [Related]
10. Atomic insight into the CD4 binding-induced conformational changes in HIV-1 gp120. Hsu ST, Bonvin AM. Proteins; 2004 May 15; 55(3):582-93. PubMed ID: 15103622 [Abstract] [Full Text] [Related]
11. Selection and characterization of an HIV-1 gp120-binding affibody ligand. Wikman M, Rowcliffe E, Friedman M, Henning P, Lindholm L, Olofsson S, Ståhl S. Biotechnol Appl Biochem; 2006 Sep 15; 45(Pt 2):93-105. PubMed ID: 16712522 [Abstract] [Full Text] [Related]
12. Computation-guided backbone grafting of a discontinuous motif onto a protein scaffold. Azoitei ML, Correia BE, Ban YE, Carrico C, Kalyuzhniy O, Chen L, Schroeter A, Huang PS, McLellan JS, Kwong PD, Baker D, Strong RK, Schief WR. Science; 2011 Oct 21; 334(6054):373-6. PubMed ID: 22021856 [Abstract] [Full Text] [Related]
13. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Wang JH, Yan YW, Garrett TP, Liu JH, Rodgers DW, Garlick RL, Tarr GE, Husain Y, Reinherz EL, Harrison SC. Nature; 1990 Nov 29; 348(6300):411-8. PubMed ID: 1701030 [Abstract] [Full Text] [Related]
17. Enzymatic labeling of biologically active envelope glycoprotein gp120 of HIV-1. Berkower I, Murphy D. Biochem Biophys Res Commun; 1993 Mar 31; 191(3):1055-65. PubMed ID: 8466484 [Abstract] [Full Text] [Related]
18. CD4 mimics as HIV entry inhibitors: lead optimization studies of the aromatic substituents. Narumi T, Arai H, Yoshimura K, Harada S, Hirota Y, Ohashi N, Hashimoto C, Nomura W, Matsushita S, Tamamura H. Bioorg Med Chem; 2013 May 01; 21(9):2518-26. PubMed ID: 23535561 [Abstract] [Full Text] [Related]
19. Click chemistry on azidoproline: high-affinity dual antagonist for HIV-1 envelope glycoprotein gp120. Gopi HN, Tirupula KC, Baxter S, Ajith S, Chaiken IM. ChemMedChem; 2006 Jan 01; 1(1):54-7. PubMed ID: 16892335 [No Abstract] [Full Text] [Related]